The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease

Chinese Critical Care Medicine

Volumn 24, Issue 4, 2012, Pages 215-218

  Wang, Hong ^a   Lu, Hong Mei ^b   Yang, Wen Hui ^b   Luo, Cheng ^b   Lu, Shan He ^b   Zhou, Ying ^b   Lin, Ying Zhong ^b  

^a Guangxi People's Hospital   (China)

^b NONE

Author keywords

Acute coronary syndrome; Coronary heart disease; Diabetes mellitus; MicroRNA 92a; Statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; MICRORNA 92A; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIAC PATIENT; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FACTORIAL ANALYSIS; FAT CONTENT; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MEMBRANE MICROPARTICLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; STABLE ANGINA PECTORIS;

EID: 84860862345     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2012.04.007     Document Type: Article

References (22)

1. O'Connell RM, Rao DS, Baltimore D. MicroRNA regulation of inflammatory responses. Annu Rev Immunol, In press 2012.
2. Lee YH, Na HS, Jeong SY, et al. Comparison of inflammatory microRNA expression in healthy and periodontitis tissues. Biocell, 2011,35:43-49.
3. Wu W, Xiao H, Laguna-Fernandez A, et al. Flow-dependent regulation of Krüppel-like factor 2 is mediated by microRNA-92a. Circulation, 2011,124:633-641.
4. Nayak L, Lin Z, Jain MK. "Go with the flow": how Krüppel-like factor 2 regulates the vasoprotective effects of shear stress. Antioxid Redox Signal, 2011,15:1449-1461.
5. Parmar KM, Larman HB, Dai G, et al. Integration of flow-dependent endothelial phenotypes by Krüppel-like factor 2. J Clin Invest, 2006,116:49-58. (Pubitemid 43121790)
6. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J, 2007,28:2525-2538. (Pubitemid 47616190)
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2010,33 Suppl 1:S62-69.
8. Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011,32:1769-1818.
9. Nicholls SJ, Ballantyne CM, Barter PJ, et al. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med, 2011,365:2078-2087.
10. Nakamura M, Yamashita T, Yajima J, et al. Impact of early statin initiation on secondary prevention in Japanese patients with coronary artery disease. J Cardiol, 2011,57:172-180.
11. Kizer JR, Madias C, Wilner B, et al. Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy. Am J Cardiol, 2010,105:1289-1296.
12. Berthe MC, Bernard M, Rasmusen C, et al. Arginine or citrulline associated with a statin stimulates nitric oxide production in bovine aortic endothelial cells. Eur J Pharmacol, 2011,670:566-570.
13. Tousoulis D, Kaski JC, Antoniades C, et al. Beneficial effects of statin treatment after myocardial infarction: is progenitor cell mobilization the missing link?. Int J Cardiol, 2008,130:301-303.
14. Schmidt-Lucke C, Fichtischerer S, Rössig L, et al. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis, 2010,211:249-254.
15. Taslipinar A, Yaman H, Yilmaz MI, et al. The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy. Scand J Clin Lab Invest, 2011,71:606-612.
16. Hsieh CH, Jeng SF, Hsieh MW, et al. Statin-induced heme oxygenase-1 increases NF-kappaB activation and oxygen radical production in cultured neuronal cells exposed to lipopolysaccharide. Toxicol Sci, 2008,102:150-159. (Pubitemid 351250477)